These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14511764)

  • 1. Current topics: brain penetrating neurotensin analog.
    Boules M; Fredrickson P; Richelson E
    Life Sci; 2003 Oct; 73(22):2785-92. PubMed ID: 14511764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive analogs of neurotensin: focus on CNS effects.
    Boules M; Fredrickson P; Richelson E
    Peptides; 2006 Oct; 27(10):2523-33. PubMed ID: 16882457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin agonists as an alternative to antipsychotics.
    Boules M; Fredrickson P; Richelson E
    Expert Opin Investig Drugs; 2005 Apr; 14(4):359-69. PubMed ID: 15882113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats.
    Fredrickson P; Boules M; Yerbury S; Richelson E
    Eur J Pharmacol; 2003 Jan; 458(1-2):111-8. PubMed ID: 12498914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
    Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
    Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
    Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization.
    Fredrickson P; Boules M; Yerbury S; Richelson E
    Brain Res; 2003 Jul; 979(1-2):245-8. PubMed ID: 12850594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats.
    Boules M; Oliveros A; Liang Y; Williams K; Shaw A; Robinson J; Fredrickson P; Richelson E
    Neuropeptides; 2011 Feb; 45(1):9-16. PubMed ID: 21047685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol.
    Cusack B; Boules M; Tyler BM; Fauq A; McCormick DJ; Richelson E
    Brain Res; 2000 Feb; 856(1-2):48-54. PubMed ID: 10677610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
    Boules M; McMahon B; Wang R; Warrington L; Stewart J; Yerbury S; Fauq A; McCormick D; Richelson E
    Brain Res; 2003 Oct; 987(1):39-48. PubMed ID: 14499944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neurotensin analog blocks cocaine-conditioned place preference and reinstatement.
    Boules M; Netz R; Fredrickson PA; Richelson E
    Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):236-9. PubMed ID: 26901162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurotensin agonist NT69L improves sensorimotor gating deficits in rats induced by a glutamatergic antagonist, but not by dopaminergic agonists.
    Secchi RL; Sung E; Hedley LR; Button D; Schreiber R
    Behav Brain Res; 2009 Sep; 202(2):192-7. PubMed ID: 19463701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity.
    Boules M; Warrington L; Fauq A; McCormick D; Richelson E
    Eur J Pharmacol; 2001 Aug; 426(1-2):73-6. PubMed ID: 11525773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat.
    Boules M; Iversen I; Oliveros A; Shaw A; Williams K; Robinson J; Fredrickson P; Richelson E
    Brain Res; 2007 Jan; 1127(1):90-8. PubMed ID: 17113052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NT69L blocks ethanol-induced increase of dopamine and glutamate levels in striatum of mouse.
    Li Z; Boules M; Richelson E
    Neurosci Lett; 2011 Jan; 487(3):322-4. PubMed ID: 20974215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties.
    Boules M; McMahon B; Warrington L; Stewart J; Jackson J; Fauq A; McCormick D; Richelson E
    Brain Res; 2001 Nov; 919(1):1-11. PubMed ID: 11689157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive Effect of Two New Neurotensin Analogues on Parkinson's Disease Rat Model.
    Lazarova M; Popatanasov A; Klissurov R; Stoeva S; Pajpanova T; Kalfin R; Tancheva L
    J Mol Neurosci; 2018 Dec; 66(4):552-560. PubMed ID: 30374780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier.
    Tyler BM; Douglas CL; Fauq A; Pang YP; Stewart JA; Cusack B; McCormick DJ; Richelson E
    Neuropharmacology; 1999 Jul; 38(7):1027-34. PubMed ID: 10428421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents.
    Boules M; Cusack B; Zhao L; Fauq A; McCormick DJ; Richelson E
    Brain Res; 2000 May; 865(1):35-44. PubMed ID: 10814731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist.
    Shilling PD; Melendez G; Priebe K; Richelson E; Feifel D
    Psychopharmacology (Berl); 2004 Sep; 175(3):353-9. PubMed ID: 15107967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.